T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| 1 |
Zoom
ZM
|
+$2.88B |
| 2 |
Eli Lilly
LLY
|
+$2.63B |
| 3 |
AstraZeneca
AZN
|
+$1.96B |
| 4 |
Fortinet
FTNT
|
+$1.66B |
| 5 |
Coupang
CPNG
|
+$1.63B |
Top Sells
| 1 |
NXP Semiconductors
NXPI
|
+$2.58B |
| 2 |
Morgan Stanley
MS
|
+$2.29B |
| 3 |
Airbnb
ABNB
|
+$2.07B |
| 4 |
NVIDIA
NVDA
|
+$1.8B |
| 5 |
Qualcomm
QCOM
|
+$1.79B |
Sector Composition
| 1 | Technology | 23.37% |
| 2 | Healthcare | 16.2% |
| 3 | Consumer Discretionary | 15.56% |
| 4 | Financials | 12.84% |
| 5 | Communication Services | 12.28% |
